MIT researchers were able to use B cells for antigen-presenting vaccines using a microfluidic cell-squeezing device. The breakthrough provided an alternative to the use of dendritic cells in these types of vaccine.
MIT researchers were able to use B cells for antigen-presenting vaccines using a microfluidic cell-squeezing device. The breakthrough provided an alternative to the use of dendritic cells in these types of vaccine.